Applied Spectral Imaging (ASI) is the maker of the GenASIs automated imaging platforms for genetic and pathology analysis.
GenASIs advanced cytogenetic and pathology platforms are the foundation of ASI’s offering. With superior imaging and analysis capabilities, ASI provides state of the art diagnostic aids, offering cytogeneticists and pathologists accurate genetic and pathology analysis. GenASIs enables automated pathology tissue analysis for primary diagnostics, creating reproducible and reliable results.
GenASIs is FDA cleared for clinical applications such as UroVysion, HER2/neu FISH, CEP XY, Karyotyping and FISH. ASI complies with the highest international quality standards including ISO, CE, CMDCAS and 21CFR part 820.
ASI has been the industry's leading provider of microscopy imaging solutions since 1993. It has over 30 registered patents in the US, Europe, Japan and the rest of the world. With worldwide offices in the US, Europe and Asia, ASI has built a global network of over 50 distributors.